Cargando…

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts

Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. Ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Jit, Mark, Levin, Carol, Brisson, Marc, Levin, Ann, Resch, Stephen, Berkhof, Johannes, Kim, Jane, Hutubessy, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582485/
https://www.ncbi.nlm.nih.gov/pubmed/23363734
http://dx.doi.org/10.1186/1741-7015-11-23
_version_ 1782260575258017792
author Jit, Mark
Levin, Carol
Brisson, Marc
Levin, Ann
Resch, Stephen
Berkhof, Johannes
Kim, Jane
Hutubessy, Raymond
author_facet Jit, Mark
Levin, Carol
Brisson, Marc
Levin, Ann
Resch, Stephen
Berkhof, Johannes
Kim, Jane
Hutubessy, Raymond
author_sort Jit, Mark
collection PubMed
description Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. Analysts informing policy decisions should address the following questions: 1) Is an economic analysis needed? 2) Should analyses address costs, epidemiological outcomes, or both? 3) If costs are considered, what sort of analysis is needed? 4) If outcomes are considered, what sort of model should be used? 5) How complex should the analysis be? 6) How should uncertainty be captured? 7) How should model results be communicated? Selecting the appropriate analysis is essential to ensure that all the important features of the decision problem are correctly represented, but that the analyses are not more complex than necessary. This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries.
format Online
Article
Text
id pubmed-3582485
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35824852013-03-08 Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts Jit, Mark Levin, Carol Brisson, Marc Levin, Ann Resch, Stephen Berkhof, Johannes Kim, Jane Hutubessy, Raymond BMC Med Correspondence Low- and middle-income countries need to consider economic issues such as cost-effectiveness, affordability and sustainability before introducing a program for human papillomavirus (HPV) vaccination. However, many such countries lack the technical capacity and data to conduct their own analyses. Analysts informing policy decisions should address the following questions: 1) Is an economic analysis needed? 2) Should analyses address costs, epidemiological outcomes, or both? 3) If costs are considered, what sort of analysis is needed? 4) If outcomes are considered, what sort of model should be used? 5) How complex should the analysis be? 6) How should uncertainty be captured? 7) How should model results be communicated? Selecting the appropriate analysis is essential to ensure that all the important features of the decision problem are correctly represented, but that the analyses are not more complex than necessary. This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries. BioMed Central 2013-01-30 /pmc/articles/PMC3582485/ /pubmed/23363734 http://dx.doi.org/10.1186/1741-7015-11-23 Text en Copyright ©2013 Jit et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Jit, Mark
Levin, Carol
Brisson, Marc
Levin, Ann
Resch, Stephen
Berkhof, Johannes
Kim, Jane
Hutubessy, Raymond
Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title_full Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title_fullStr Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title_full_unstemmed Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title_short Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
title_sort economic analyses to support decisions about hpv vaccination in low- and middle-income countries: a consensus report and guide for analysts
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582485/
https://www.ncbi.nlm.nih.gov/pubmed/23363734
http://dx.doi.org/10.1186/1741-7015-11-23
work_keys_str_mv AT jitmark economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT levincarol economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT brissonmarc economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT levinann economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT reschstephen economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT berkhofjohannes economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT kimjane economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts
AT hutubessyraymond economicanalysestosupportdecisionsabouthpvvaccinationinlowandmiddleincomecountriesaconsensusreportandguideforanalysts